AMSA and Amiodarone Study in Cardiac Arrest
Key facts
- Who runs it
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Where
- Italy, Norway, and Spain4 sites in 3 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 629 people enrolled
- Started
- 1 Jan 2015
- Ended
- 31 Dec 2023
- Type of study
- Observational, 2 groups
- Treatments tested
- Amiodarone Injection
- Record updated
- 8 March 2024
Who can take part
- Age
- 1 year to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- clinical:
- patients with out-of-hospital cardiac arrest
- shockable presenting rhythm
- resuscitation attempted
- advanced resuscitation attempted; technical: - VF cardiac arrest (and not VT)
Who cannot take part
- clinical:
- non-shockable presenting rhythm
- resuscitation not attempted; technical:
- AMSA not evaluable
Where is this trial?
It has sites in 3 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Investigators' aim is to assess whether the administration of amiodarone during resuscitation could cause a reduction of the values of the amplitude spectral area (AMSA).
Read full original descriptionShow less
Amiodarone is recommended for the treatment of cardiac arrest due to ventricular tachycardia/ventricular fibrillation (VT/VF) ( with a low level of recommendation cause of conflicting results. AMSA is a parameter expressing the amplitude of VF and it has been shown to predict defibrillation success and the return of spontaneous circulation (ROSC). No data are available so far about the impact of amiodarone administration on AMSA values.
The 2 groups in the trial
- Amiodarone group
Patients who did receive amiodarone during the attempt of resuscitation
Treatment: Amiodarone Injection
- NO Amiodarone
Patients who did receive amiodarone during the attempt of resuscitation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- aMsa and amiOdarone Study in cArdiaC Arrest
- Record updated
- 8 March 2024